EpiCast Report: Venous Thromboembolism - Epidemiology Forecast to 2025
SKU ID :GD-10235121 | Published Date: 18-Jul-2016 | No. of pages: 69Description
TOC
1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 6
2 Epidemiology 7
2.1 Disease Background 7
2.2 Risk Factors and Comorbidities 8
2.3 Global Trends 10
2.4 Forecast Methodology 11
2.4.1 Sources Used 11
2.4.2 Forecast Assumptions and Methods 17
2.4.3 Sources Not Used 33
2.5 Epidemiological Forecast for VTE (2015-2025) 34
2.5.1 Pulmonary Embolism 34
2.5.2 Deep Vein Thrombosis 37
2.5.3 VTE 40
2.5.4 Number of Hospital Discharges Meeting Criteria for Medically Ill and Those at Risk for VTE 50
2.5.5 Number of Primary Total Knee Replacements and Revisions 51
2.5.6 Number of Hip Replacements 53
2.6 Discussion 55
2.6.1 Epidemiological Forecast Insight 55
2.6.2 Limitations of the Analysis 56
2.6.3 Strengths of the Analysis 57
3 Appendix 58
3.1 Bibliography 58
3.2 Physicians and Specialists Included in this Study 61
3.3 About the Authors 64
3.3.1 Epidemiologists 64
3.3.2 Reviewers 64
3.3.3 Global Director of Therapy Analysis and Epidemiology 65
3.3.4 Global Head of Healthcare 66
3.4 About GlobalData 67
3.5 About EpiCast 67
3.6 Disclaimer 68
Tables & Figures
1.1 List of Tables
Table 1: Risk Factors and Comorbidities for VTE 9
Table 2: 8MM, Sources Used to Forecast the Diagnosed Incident Cases of PE 12
Table 3: 8MM, Sources Used to Forecast the Diagnosed Incident Cases of DVT 13
Table 4: 8MM, Sources Used to Forecast the Number of Hospital Discharges that Meet the Criteria for Medically Ill 14
Table 5: 6MM, Sources Used to Forecast Primary Total Knee Replacements 15
Table 6: 6MM, Sources Used to Forecast the Rate of Primary Total Knee Replacement Requiring Revisions 15
Table 7: Japan and China, Sources Used to Forecast Primary Total Knee Replacements and Revisions 16
Table 8: 8MM, Sources Used to Forecast Hip Replacements 16
Table 9: 8MM, Diagnosed Incident Cases of PE, All Ages, Both Sexes, Select Years 2015-2025 35
Table 10: 8MM, Diagnosed Incident Cases of DVT, All Ages, Both Sexes, Select Years 2015-2025 38
Table 11: 8MM, Diagnosed Incident Cases of VTE, All Ages, Both Sexes, Select Years 2015-2025 41
Table 12: 8MM, Age-Specific Diagnosed Incident Cases of VTE, Both Sexes, N (Row %), 2015 43
Table 13: 8MM, Sex-Specific Diagnosed Incident Cases of VTE, Both Sexes, N (Row %), 2015 45
Table 14: 8MM, Number of Recurrent VTE Cases One and 10 Years After Incident VTE Event, Both Sexes, All Ages, N, 2015 47
Table 15: 8MM, Number of VTE Cases With Cancer Comorbidity, Both Sexes, All Ages, N, 2015 and 2025 48
Table 16: 8MM, Number of VTE Attacks, Both Sexes, All Ages, N, 2015-2025 49
Table 17: 8MM, Number of Hospital Discharges Meeting Criteria for Medically Ill; Those at risk for VTE, Both Sexes, Ages ≥40 Years, N, 2015 51
Table 18: 8MM, Number of Primary Total Knee Replacements and Revisions, Both Sexes, Ages ≥15 Years 52
Table 19: 8MM, Number of Hip Replacements, Both Sexes, Ages ≥15 Years 54
1.2 List of Figures
Figure 1: 8MM, Diagnosed Incident Cases of PE, All Ages, Both Sexes, Select Years 2015-2025 36
Figure 2: Age-Standardized Diagnosed Incidence of PE, All Ages, Cases Per 100,000, 2015 37
Figure 3: 8MM, Diagnosed Incident Cases of DVT, All Ages, Both Sexes, Select Years 2015-2025 39
Figure 4: Age-Standardized Diagnosed Incidence of DVT, All Ages, Cases Per 100,000 Population, 2015 40
Figure 5: 8MM, Diagnosed Incident Cases of VTE, All Ages, Both Sexes, Select Years 2015-2025 42
Figure 6: 8MM, Age-Specific Diagnosed Incident Cases of VTE, Both Sexes, N (Row %), 2015 44
Figure 7: 8MM, Sex-Specific Diagnosed Incident Cases of VTE, Both Sexes, N, 2015 46
Figure 8: 8MM, Number of VTE Attacks, Both Sexes, All Ages, N, 2015-2025 50
Figure 9: 8MM, Number of Primary Total Knee Replacements and Revisions, Both Sexes, Ages ≥15 Years 53
Figure 10: 8MM, Number Hip Replacements, Both Sexes, Ages ≥15 Years 55
Companies
- PRICE
-
$3995$11985